Cardiac Biomarkers Market Size Comprehensive Analysis, Growth Forecast from 2019 to 2025

Market Study Report LLC adds “Global Cardiac Biomarkers Market Report” new report to its research database. The report spread across 106 pages with 125 table and figures in it. The report provides information on Industry Trends, Demand, Top Manufacturers, Countries, Material and Application.

North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.

Request a sample of this premium report titled Global Cardiac Biomarkers Market Professional Survey Report 2019 at

Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator for particular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.

There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.

This report focuses on Cardiac Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Biomarkers market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Cardiac Biomarkers in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Cardiac Biomarkers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

• Abbott
• Alere
• F. Hoffmann-La Roche
• Advanced ImmunoChemical
• AgPlus Diagnostics
• BG Medicine
• BioLegend
• bioMrieux
• Bio-Rad Laboratories

Segment by Regions

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Segment by Type

• Troponin
• Natriuretic Peptides - BNP and NT-proBNP
• Myoglobin
• Others

Segment by Application

• Acute Coronary Syndrome
• Myocardial Infarction
• Congestive Heart Failure
• Others

Request a discount on standard prices of this premium report titled Global Cardiac Biomarkers Market Professional Survey Report 2019 at

Table of Contents:

Executive Summary

1 Industry Overview of Cardiac Biomarkers
1.1 Definition of Cardiac Biomarkers
1.2 Cardiac Biomarkers Segment by Type
1.2.1 Global Cardiac Biomarkers Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Natriuretic Peptides - BNP and NT-proBNP
1.2.5 Myoglobin
1.2.6 Others
1.3 Cardiac Biomarkers Segment by Applications
1.3.1 Global Cardiac Biomarkers Consumption Comparison by Applications (2014-2025)
1.3.2 Acute Coronary Syndrome
1.3.3 Myocardial Infarction
1.3.4 Congestive Heart Failure
1.3.5 Others
1.4 Global Cardiac Biomarkers Overall Market
1.4.1 Global Cardiac Biomarkers Revenue (2014-2025)
1.4.2 Global Cardiac Biomarkers Production (2014-2025)
1.4.3 North America Cardiac Biomarkers Status and Prospect (2014-2025)
1.4.4 Europe Cardiac Biomarkers Status and Prospect (2014-2025)
1.4.5 China Cardiac Biomarkers Status and Prospect (2014-2025)
1.4.6 Japan Cardiac Biomarkers Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cardiac Biomarkers Status and Prospect (2014-2025)
1.4.8 India Cardiac Biomarkers Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cardiac Biomarkers
2.3 Manufacturing Process Analysis of Cardiac Biomarkers
2.4 Industry Chain Structure of Cardiac Biomarkers
3 Development and Manufacturing Plants Analysis of Cardiac Biomarkers
3.1 Capacity and Commercial Production Date
3.2 Global Cardiac Biomarkers Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cardiac Biomarkers
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Cardiac Biomarkers Production and Capacity Analysis
4.2 Cardiac Biomarkers Revenue Analysis
4.3 Cardiac Biomarkers Price Analysis
4.4 Market Concentration Degree
5 Cardiac Biomarkers Regional Market Analysis
5.1 Cardiac Biomarkers Production by Regions
5.1.1 Global Cardiac Biomarkers Production by Regions
5.1.2 Global Cardiac Biomarkers Revenue by Regions
5.2 Cardiac Biomarkers Consumption by Regions
5.3 North America Cardiac Biomarkers Market Analysis
5.3.1 North America Cardiac Biomarkers Production
5.3.2 North America Cardiac Biomarkers Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cardiac Biomarkers Import and Export
5.4 Europe Cardiac Biomarkers Market Analysis
5.4.1 Europe Cardiac Biomarkers Production
5.4.2 Europe Cardiac Biomarkers Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cardiac Biomarkers Import and Export
5.5 China Cardiac Biomarkers Market Analysis
5.5.1 China Cardiac Biomarkers Production
5.5.2 China Cardiac Biomarkers Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cardiac Biomarkers Import and Export
5.6 Japan Cardiac Biomarkers Market Analysis
5.6.1 Japan Cardiac Biomarkers Production
5.6.2 Japan Cardiac Biomarkers Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cardiac Biomarkers Import and Export

More Details on this Report At:

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Read More:

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910

Release ID: 88925337